Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells. (January 2018)
- Record Type:
- Journal Article
- Title:
- Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells. (January 2018)
- Main Title:
- Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells
- Authors:
- Nürnberg, Christina
Kociok, Norbert
Brockmann, Claudia
Lischke, Timo
Crespo-Garcia, Sergio
Reichhart, Nadine
Wolf, Susanne
Baumgrass, Ria
Eming, Sabine A.
Beer-Hammer, Sandra
Joussen, Antonia M. - Abstract:
- Abstract: Anti-VEGF-directed therapies have been a milestone for treating retinal vascular diseases. Depletion of monocyte lineage cells suppresses pathological neovascularization in the oxygen-induced retinopathy mouse model. However, the question whether myeloid-derived VEGF-A expression is responsible for the pathogenesis in oxygen-induced retinopathy remained unknown. We analyzed LysMCre-driven myeloid cell-specific VEGF-A knockout mice as well as mice with complete depletion of circulating macrophages through clodronate-liposome treatment in the oxygen-induced retinopathy model by immunohistochemistry, qPCR, and flow cytometry. Furthermore, we analyzed VEGF-A mRNA expression in MIO-M1 cells alone and in co-culture with BV-2 cells in vitro . The myeloid cell-specific VEGF-A knockout did not change relative retinal VEGF-A mRNA levels, the relative avascular area or macrophage/granulocyte numbers in oxygen-induced retinopathy and under normoxic conditions. We observed an insignificantly attenuated pathology in systemically clodronate-liposome treated knockouts but evident VEGF-A expression in activated Müller cells on immunohistochemically stained sections. MIO-M1 cells had significantly higher expression levels of VEGF-A in co-culture with BV-2 cells compared to cultivating MIO-M1 cells alone. Our data show that myeloid-derived cells contribute to pathological neovascularization in oxygen-induced retinopathy through activation of VEGF-A expression in Müller cells.Abstract: Anti-VEGF-directed therapies have been a milestone for treating retinal vascular diseases. Depletion of monocyte lineage cells suppresses pathological neovascularization in the oxygen-induced retinopathy mouse model. However, the question whether myeloid-derived VEGF-A expression is responsible for the pathogenesis in oxygen-induced retinopathy remained unknown. We analyzed LysMCre-driven myeloid cell-specific VEGF-A knockout mice as well as mice with complete depletion of circulating macrophages through clodronate-liposome treatment in the oxygen-induced retinopathy model by immunohistochemistry, qPCR, and flow cytometry. Furthermore, we analyzed VEGF-A mRNA expression in MIO-M1 cells alone and in co-culture with BV-2 cells in vitro . The myeloid cell-specific VEGF-A knockout did not change relative retinal VEGF-A mRNA levels, the relative avascular area or macrophage/granulocyte numbers in oxygen-induced retinopathy and under normoxic conditions. We observed an insignificantly attenuated pathology in systemically clodronate-liposome treated knockouts but evident VEGF-A expression in activated Müller cells on immunohistochemically stained sections. MIO-M1 cells had significantly higher expression levels of VEGF-A in co-culture with BV-2 cells compared to cultivating MIO-M1 cells alone. Our data show that myeloid-derived cells contribute to pathological neovascularization in oxygen-induced retinopathy through activation of VEGF-A expression in Müller cells. Highlights: A myeloid cell-specific VEGF-A knockout in mice does not change the VEGF-A mRNA level in the retina. Thus, myeloid-derived cells themselves are not a source of relevant VEGF-A levels in the retina. Müller cells co-cultured with microglia cells have a three to five fold higher expression level of VEGF-A than cultured alone. Activated myeloid-derived cells trigger Müller cell VEGF-A secretion, thus contributing to pathological neovascularization in OIR. … (more)
- Is Part Of:
- Experimental eye research. Volume 166(2018)
- Journal:
- Experimental eye research
- Issue:
- Volume 166(2018)
- Issue Display:
- Volume 166, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 166
- Issue:
- 2018
- Issue Sort Value:
- 2018-0166-2018-0000
- Page Start:
- 56
- Page End:
- 69
- Publication Date:
- 2018-01
- Subjects:
- VEGF -- Oxygen induced retinopathy -- Myeloid derived cells -- Macrophages -- Microglia cells
GFAP glial fibrillary acidic protein -- LysMCre a nuclear-localized Cre recombinase inserted into the first coding ATG of the lysozyme 2 gene of the mouse -- OIR oxygen induced retinopathy -- RPE retinal pigment epithelium -- VEGF vascular endothelial factor -- VEGFR1 vascular endothelial factor receptor 1
Ophthalmology -- Periodicals
Eye -- Periodicals
Œil -- Périodiques
Ophthalmology
Periodicals
Electronic journals
612.8405 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00144835 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0014-4835;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.exer.2017.10.011 ↗
- Languages:
- English
- ISSNs:
- 0014-4835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3839.150000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5587.xml